Impact of US Healthcare Reform on the In Vitro Diagnostics Market

Patient Influx and Increased Testing Will Steer Clinical Labs toward ACO Models

Regular Price: USD 2,450.00

Special Price USD 2,205.00

10% OFF

* Required Fields

Regular Price: USD 2,450.00

Special Price USD 2,205.00


Be the first to review this product

This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segments—immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose—are provided. Key market drivers and restraints and the competitive landscape for the global market are discussed. The base year is 2013.

Table of Contents

Executive SummaryExecutive SummaryEffects of Healthcare ReformThe Patient Protection and Affordable Care ActEffects on Clinical LabsOpportunities for IVD Manufacturers and Clinical LabsCare Delivery Transformation: Acute Care to PreventionOpportunity Impact DashboardLaboratory Test ReimbursementFactors Affecting Pathology LabsMost Impacted Specialty M&As Declined in 2012 and Remained Flat in 20136 Factors Affecting the CLFS Short-term Projection of CLFS Cuts from the ACAProjected CLFS ReductionsAffordable Care Act EffectsAccountable Care OrganizationsPositioning a Clinical Lab within an ACO EcosystemValue of Clinical Analytics to a Clinical LabPotential Laboratory StrategiesDemands and Expectations of ACOsIVD Market OverviewMarket SegmentationMarket OverviewKey Market PrinciplesTest Volume by SpecialtyCompetitive LandscapeSegment Life Cycle AnalysisDecentralization vs. CentralizationTechnology and Market Trends—Tissue Diagnostics SegmentTissue Diagnostics Segment SnapshotTissue Diagnostics Segment—US Pricing AnalysisTissue Diagnostics Segment—Global StrategiesTissue Diagnostics Segment—Three Big PredictionsTechnology and Market Trends—Molecular Diagnostics SegmentMolecular Diagnostics Segment SnapshotMolecular Diagnostics Segment—Application AreasMolecular Diagnostics Segment—Market Size and GrowthMolecular Diagnostics Segment—Next-generation Sequencing SnapshotMolecular Diagnostics Segment—Evolution of NGS TechnologiesMolecular Diagnostics Segment—Applications Based on NGSMolecular Diagnostics Segment—Key NGS Technology Partnerships and AcquisitionsMolecular Diagnostics Segment—Molecular Technologies in Companion DiagnosticsMolecular Diagnostics Segment—MiniaturizationMolecular Diagnostics Segment—Three Big PredictionsTechnology and Market Trends—Point-of-care Testing SegmentPoint-of-care Testing Segment SnapshotPoint-of-care Testing Segment—Sales BreakdownPoint-of-care Testing Segment—POCT vs. Laboratory TestingPoint-of-care Testing Segment—Key TrendsPoint-of-care Testing Segment—Key Trends (continued)Point-of-care Testing Segment—Metrics AnalysisPoint-of-care Testing Segment—Metrics Analysis (continued) Point-of-care Testing Segment—Potential OpportunitiesPoint-of-care Testing Segment—Three Big PredictionsTechnology and Market Trends—Self-monitoring Blood GlucoseSelf-monitoring Blood Glucose Segment SnapshotSelf-monitoring Blood Glucose Segment—Test Strips Market Metrics AnalysisSelf-monitoring Blood Glucose Segment—Meters Market Metrics AnalysisSelf-monitoring Blood Glucose Segment—Product AnalysisTechnology and Market Trends—Clinical Microbiology SegmentClinical Microbiology Segment SnapshotClinical Microbiology Segment—Microbiology SegmentationClinical Microbiology Segment—Emerging OpportunitiesClinical Microbiology Segment—Unmet Demands by ManufacturersClinical Microbiology Segment—Technology TrendsTechnology and Market Trends—Hematology and Hemostasis SegmentsHematology Segment SnapshotHemostasis Segment SnapshotHematology and Hemostasis Segments—Opportunities for Market VendorsTechnology and Market Trends—Immunochemistry SegmentImmunochemistry Segment SnapshotImmunochemistry Segment—Installed BaseConclusionsConclusionsLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue PropositionGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Related Research

Release Date : 20-Dec-17

Region : North America

Release Date : 17-Jul-17

Region : North America

Release Date : 24-Dec-2015

Region : Europe

Release Date : 11-Nov-2015

Region : Asia Pacific

Release Date : 22-Oct-2015

Region : North America

Release Date : 07-Sep-2015

Region : North America

Release Date : 17-Jul-2015

Region : North America

Release Date : 01-Jul-2015

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.